CA2785228A1 - Composition pharmaceutique a action antimicrobienne pour administration parenterale, et procede de production - Google Patents

Composition pharmaceutique a action antimicrobienne pour administration parenterale, et procede de production Download PDF

Info

Publication number
CA2785228A1
CA2785228A1 CA2785228A CA2785228A CA2785228A1 CA 2785228 A1 CA2785228 A1 CA 2785228A1 CA 2785228 A CA2785228 A CA 2785228A CA 2785228 A CA2785228 A CA 2785228A CA 2785228 A1 CA2785228 A1 CA 2785228A1
Authority
CA
Canada
Prior art keywords
parenteral administration
pharmaceutical composition
silicon dioxide
weight
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2785228A
Other languages
English (en)
Inventor
Viktor Lvovich Limonov
Konstantin Valentinovich Gaidul
Aleksandr Valerevich Dushkin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2785228A1 publication Critical patent/CA2785228A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2785228A 2010-09-13 2011-05-11 Composition pharmaceutique a action antimicrobienne pour administration parenterale, et procede de production Abandoned CA2785228A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU201001449 2010-09-13
EA201001449A EA021874B1 (ru) 2010-09-13 2010-09-13 Фармацевтическая композиция антимикробного действия для парентерального введения и способ ее получения
PCT/RU2011/000320 WO2012036585A1 (fr) 2010-09-13 2011-05-11 Composition pharmaceutique à action antimicrobienne pour administration parentérale, et procédé de production

Publications (1)

Publication Number Publication Date
CA2785228A1 true CA2785228A1 (fr) 2012-03-22

Family

ID=45908207

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2785228A Abandoned CA2785228A1 (fr) 2010-09-13 2011-05-11 Composition pharmaceutique a action antimicrobienne pour administration parenterale, et procede de production

Country Status (9)

Country Link
JP (1) JP2013537190A (fr)
CN (1) CN103096896A (fr)
AU (1) AU2011302724C1 (fr)
BR (1) BR112012023964A2 (fr)
CA (1) CA2785228A1 (fr)
EA (1) EA021874B1 (fr)
MX (1) MX2012010535A (fr)
NZ (1) NZ598831A (fr)
WO (1) WO2012036585A1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3180350B2 (ja) * 1996-02-29 2001-06-25 藤沢薬品工業株式会社 β―ラクタム系抗生物質含有錠剤およびその製造法
US20100172993A1 (en) * 2006-08-11 2010-07-08 Amarjit Singh Particles for delivery of active ingredients, process of making and compositions thereof
RU2377985C2 (ru) 2006-12-25 2010-01-10 Сергей Михайлович Юдин Средство для лечения инфекционных болезней, вызванных множественно-устойчивыми бактериями

Also Published As

Publication number Publication date
EA021874B1 (ru) 2015-09-30
WO2012036585A1 (fr) 2012-03-22
CN103096896A (zh) 2013-05-08
MX2012010535A (es) 2012-11-16
WO2012036585A8 (fr) 2012-10-04
AU2011302724C1 (en) 2012-11-29
EA201001449A1 (ru) 2012-02-28
AU2011302724B2 (en) 2012-06-28
BR112012023964A2 (pt) 2016-08-02
AU2011302724A1 (en) 2012-05-03
NZ598831A (en) 2013-11-29
JP2013537190A (ja) 2013-09-30

Similar Documents

Publication Publication Date Title
SG196818A1 (en) Processes and compositions for liposomal and efficient delivery of gene silencing therapeutics
WO2011042463A3 (fr) Composition pharmaceutique comprenant un principe actif médiocrement soluble et un polymère hyper-ramifié
CN102600081B (zh) 一种阿莫西林钠克拉维酸钾注射剂及其制备方法
WO2012039642A8 (fr) Composition pharmaceutique à action antimicrobienne et cicatrisante pour application externe, et procédé de fabrication
CA2785228A1 (fr) Composition pharmaceutique a action antimicrobienne pour administration parenterale, et procede de production
AU2012211402B2 (en) Pharmaceutical composition for the preparation of infusion solutions of antimicrobial preparations, its' production process
UA103118C2 (ru) Фармацевтическая композиция антимикробного действия для парентерального введения и способ ее получения
UA103116C2 (ru) Порошкообразная фармацевтическая композиция антимикробного и противовоспалительного действия для парентерального введения, которая содержит фосфомицин и высокодисперсный наноструктурированный диоксид кремния, способ ее получения
EA201100735A1 (ru) Фармацевтическая композиция антибактериального действия для парентерального применения, способ ее получения
JP2024532611A (ja) 鼻腔薬物送達用の粘膜接着ポリマー
CN105456268A (zh) 哌拉西林钠他唑巴坦钠的复方药物组合物及其制备方法
EA201100733A1 (ru) Фармацевтическая композиция для лечения туберкулеза и других инфекций, способ ее получения
NZ601748B (en) Pharmaceutical composition for the preparation of infusion solutions of antimicrobial preparations, its' production process
CN102406612A (zh) 克拉维酸钾可溶性粉剂及其制备方法
EA201100736A1 (ru) Фармацевтическая композиция антимикробного действия для парентерального применения, способ ее получения
KR20100058226A (ko) 동물용 복합항생제 조성물

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead

Effective date: 20150512